You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

Article info

Article menu
Clinical care/Education/Nutrition
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

Authors

  • Anxious J Niwaha Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UKNCD Theme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda PubMed articlesGoogle scholar articles
  • Lauren R Rodgers Institute of Health Research, University of Exeter Medical School, Exeter, UK PubMed articlesGoogle scholar articles
  • Alice L J Carr Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK PubMed articlesGoogle scholar articles
  • Priscilla A Balungi Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UKNCD Theme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda PubMed articlesGoogle scholar articles
  • Raymond Mwebaze Department of Medicine, St. Francis Hospital Nsambya, Kampala, Uganda PubMed articlesGoogle scholar articles
  • Andrew T Hattersley Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UKMacleod Diabetes and Endocrine Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  • Beverley M Shields Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK PubMed articlesGoogle scholar articles
  • Moffat J Nyirenda NCD Theme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaNCD Epidemiology, London School of Hygiene & Tropical Medicine, London, UK PubMed articlesGoogle scholar articles
  • Angus G Jones Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UKMacleod Diabetes and Endocrine Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Angus G Jones; Angus.Jones{at}exeter.ac.uk
View Full Text

Citation

Niwaha AJ, Rodgers LR, Carr ALJ, et al
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study
BMJ Open Diabetes Research and Care 2022;10:e002714. doi: 10.1136/bmjdrc-2021-002714

Publication history

  • Received November 29, 2021
  • Accepted March 27, 2022
  • First published April 21, 2022.
Online issue publication 
April 21, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.